Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, presented data at the International Oncolytic Virotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback